- Featured Product
- KD/KO Validated
Bcl-XL Polyclonal Antibody for FC, IF, IHC, IP, WB, ELISA
Cat no : 10783-1-AP
Apoptosis regulator Bcl X, BCL2L1, Bcl-XL
Validation Data Gallery
|Positive WB detected in||A549 cells, Raji cells, mouse placenta tissue, HepG2 cells, C6 cells, Jurkat cells, K-562 cells, human placenta tissue, NIH/3T3 cells, RAW264.7, HeLa cells, rat brain tissue|
|Positive IP detected in||K-562 cells|
|Positive IHC detected in||human lung cancer tissue, human colon tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||NIH/3T3 cells|
|Positive FC detected in||Jurkat cells|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
10783-1-AP targets Bcl-XL in FC, IF, IHC, IP, WB, ELISA applications and shows reactivity with human, mouse, rat samples.
|Reactivity||human, mouse, rat|
|Cited Species||human, mouse, rat, sheep|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Bcl-XL fusion protein Ag1232|
|Full Name||BCL2-like 1|
|Calculated molecular weight||26 kDa|
|Observed molecular weight||30 kDa|
|GenBank accession number||BC019307|
|Gene ID (NCBI)||598|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.1% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20oC. Aliquoting is unnecessary for -20oC storage.|
BCL2L1 is a member of the BCL-2 protein family. BCL2L1 is expressed as three isoforms, Bcl-X(L),Bcl-X(s) and Bcl-X(beta) , and is located at the outer mitochondrial membrane. The Bcl-X(L) isoform is a 233 amino acid protein, acting as an apoptotic inhibitor. Bcl-XL can forms heterodimers with BAX, BAK or BCL2, and the heterodimerization with BAX does not seem to be required for anti-apoptotic activity. The Bcl-X(s) isoform is a shorter variant that is 178 amino acids in length and lacks a 63 amino acid region (amino acids 126-188), acting as an apoptotic activator. Bcl-X(beta) is a 227 amino acid protein. This antibody can recognize Bcl-XL, Bcl-X(s) and Bcl-X(Beta).
|Product Specific Protocols|
|WB protocol for Bcl-XL antibody 10783-1-AP||Download protocol|
|IHC protocol for Bcl-XL antibody 10783-1-AP||Download protocol|
|IF protocol for Bcl-XL antibody 10783-1-AP||Download protocol|
|IP protocol for Bcl-XL antibody 10783-1-AP||Download protocol|
|FC protocol for Bcl-XL antibody 10783-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion.
Biochem Biophys Res Commun
Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.
Protective Effect of Extract of Bletilla Striata on Isoflurane Induced Neuronal Injury By Altering PI3K/Akt Pathway.
Cell Biol Int
Soluble CXCL16 Promotes TNF-α-induced Apoptosis in DLBCL via the AMAD10-NF-κB Regulatory Feedback Loop.
A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways.
Biochem Biophys Res Commun
Alisol B-23-acetate, a tetracyclic triterpenoid isolated from Alisma orientale, induces apoptosis in human lung cancer cells via the mitochondrial pathway.